Progenity Stock Analysis

PROG -  USA Stock  

USD 3.06  0.08  2.55%

The big decline in price over the last few months for Progenitymay encourage shareholders to take a closer look at the company as it is trading at a share price of 3.06 on 523,862 in trading volume. The company management teams failed to add value to investors and positioning the company supply of money to exploit market volatility in May. However, diversifying your holdings with Progenity or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 6.96. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Progenity partners.
Please check Your Equity Center.

Search Stock Analysis 

The Progenity stock analysis report makes it easy to digest most publicly released information about Progenity and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Progenity stock analysis module also helps to analyze the Progenity price relationship with some important fundamental indicators such as market cap and management efficiency.

Progenity Stock Analysis Notes

About 25.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. The company was founded in 2010 and is headquartered in San Diego, California. Progenity operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 635 people. To find out more about Progenity contact the company at 855 293 2639 or learn more at

Progenity Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Progenity's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Progenity or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Progenity generates negative expected return over the last 90 days
Progenity has high historical volatility and very poor performance
Progenity has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 74.31 M. Net Loss for the year was (192.8 M) with loss before overhead, payroll, taxes, and interest of (19.12 M).
Progenity currently holds about 92.08 M in cash with (165.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.53.
Roughly 62.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Purchase by Athyrium Capital Management Lp of 8097166 shares of Progenity

Progenity Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Progenity is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Progenity backward and forwards among themselves. Progenity's institutional investor refers to the entity that pools money to purchase Progenity's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Athyrium Capital Management LpCommon Shares27 M128.7 M
Neuberger Berman Group LlcCommon Shares6.5 M31.1 M
Armistice Capital LlcCommon Shares2.6 M12.5 M
Altium Capital Management LpCommon Shares1.7 M8.3 M
Blackrock IncCommon Shares1.2 M5.6 M
Vanguard Group IncCommon Shares759.7 K3.6 M
Driehaus Capital Management LlcCommon Shares663.1 K3.2 M
Note, although Progenity's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Progenity Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 189.47 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Progenity's market, we take the total number of its shares issued and multiply it by Progenity's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Progenity Profitablity

Progenity's profitability indicators refer to fundamental financial ratios that showcase Progenity's ability to generate income relative to its revenue or operating costs. If, let's say, Progenity is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Progenity's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Progenity's profitability requires more research than a typical breakdown of Progenity's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (259.08) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (262.66) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -2.63.

Management Efficiency

The entity has return on total asset (ROA) of (95.25) % which means that it has lost $95.25 on every $100 spent on asset. This is way below average. Progenity management efficiency ratios could be used to measure how well progenity manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 17th of June 2021, Progenity holds the risk adjusted performance of (0.026531), and Coefficient Of Variation of (1,754). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Progenity, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down and interpolate data for nineteen technical drivers for Progenity, which can be compared to its competitors. Please check Progenity variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Progenity is priced some-what accurately, providing market reflects its current price of 3.06 per share. Given that Progenity has jensen alpha of (0.46), we recommend you to check out Progenity's recent market performance to make sure the company can sustain itself at a future point.

Progenity Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Exponential Moving Average is calculated by weighting recent values of Progenity more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Progenity Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Progenity insiders, such as employees or executives, is commonly permitted as long as it does not rely on Progenity's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Progenity insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Progenity Predictive Daily Indicators

Progenity intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Progenity stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Progenity Forecast Models

Progenity time-series forecasting models is one of many Progenity's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Progenity's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Progenity Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Progenity stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Progenity shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Progenity. By using and applying Progenity Stock analysis, traders can create a robust methodology for identifying Progenity entry and exit points for their positions.
Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. It offers Innatal, a noninvasive prenatal screening test offered to women early in pregnancy to screen for chromosome abnormalities, such as down syndrome, trisomy 18, trisomy 13, and sex chromosome disorders through the analysis of cell-free DNA Preparent that screens for carrier status of hereditary diseases prior to or early in pregnancy and Riscover, a hereditary cancer screen that analyzes 31 genes associated with inherited risk of 12 types of cancers, including the BRCA12 genes for hereditary breast, ovarian, colorectal, endometrial, pancreatic, and other cancer syndromes, as well as for the five genes associated with Lynch syndrome. The company also provides Resura, a noninvasive prenatal test for families at risk for rare single gene disorders and Preecludia, a preeclampsia rule-out test. In addition, it offers anatomic and molecular pathology tests, and COVID-19 PCR testing services, as well as test products that includes chromosomal microarray for pregnancy loss, which evaluates the genetic cause of miscarriage maternal serum screening for chromosomal disorders and preimplantation genetic testing for use with artificial reproductive technologies. Further, the company develops therapeutic solutions for gastrointestinal-related disorders, such as PGN-001, PGN-300, PGN-600, and PGN-OB2. It also owns and operates laboratory. Progenity, Inc. was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November 2013. The company was founded in 2010 and is headquartered in San Diego, California.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Progenity to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Commodity Channel Index Now


Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module
Please check Your Equity Center. Note that the Progenity information on this page should be used as a complementary analysis to other Progenity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Progenity Stock analysis

When running Progenity stock analysis, check to measure Progenity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progenity is operating at the current time. Most of Progenity's stock examination focuses on studying past and present price action to predict the probability of Progenity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Progenity's price. Additionally, you may evaluate how the addition of Progenity to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
The market value of Progenity is measured differently than its book value, which is the value of Progenity that is recorded on the company's balance sheet. Investors also form their own opinion of Progenity stock's value that differs from its market value or its book value, called intrinsic value, which is Progenity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Progenity's market value can be influenced by many factors that don't directly affect Progenity underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Progenity's stock value and its price as these two are different measures arrived at by different means. Investors typically determine Progenity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Progenity's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.